Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPLACE: Hydrocortisone vs Placebo for Adrenal Insufficiency After Glucocorticoid Cessation in PMR/GCA
NCT05193396Phase 4Recruiting
- Start
- Feb 2022
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydrocortisone in adrenal insufficiency (AI). Started Feb 2022; status: recruiting.
02
Drugs
hydrocortisone
03
Conditions
adrenal insufficiency (AI)
Beyond the preview
Go deeper on NCT05193396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05193396.